Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma

被引:5
作者
Okabe, Kazunori [1 ]
机构
[1] Natl Hosp Org, Yamaguchi Ube Med Ctr, Div Thorac Surg, Ube, Higashikiwa, Japan
关键词
Chemotherapy; hyperthermia; mesothelioma; surgery; POVIDONE-IODINE; PLEURECTOMY/DECORTICATION; LAVAGE;
D O I
10.21037/atm.2017.03.78
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant pleural mesothelioma (MPM) is a dreadful disease with a poor prognosis. Multimodality therapy including surgical macroscopic complete resection is performed to treat operable MPM. Intraoperative intracavitary hyperthermic chemotherapy for MPM was reviewed. Appropriate papers published between 2006 and present were extracted by the PubMed advanced search by MPM (Title/Abstract), chemotherapy (Title/Abstract), and hyperthermia (All fields). Among the selected papers, those written in English, and treated more than ten MPM patients were reviewed. The intraoperative intracavitary hyperthermic chemotherapy has been performed following extrapleural pneumonectomy (EPP) or pleurectomy/decortication (P/D) for MPM. Cisplatin was mainly used for perfusion, and the morbidity and mortality was acceptable. In conclusion, the intraoperative intracavitary hyperthermic chemotherapy following EPP or P/D for MPM might enhance local control in the chest cavity.
引用
收藏
页数:4
相关论文
共 8 条
[1]   Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience [J].
Lang-Lazdunski, Loic ;
Bille, Andrea ;
Papa, Sophie ;
Marshall, Stuart ;
Lal, Rohit ;
Galeone, Carlotta ;
Landau, David ;
Steele, Jeremy ;
Spicer, James .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 149 (02) :558-566
[2]   Hyperthermic Chemoperfusion for the Treatment of Malignant Pleural Mesothelioma [J].
Mujoomdar, Aneil A. ;
Sugarbaker, David J. .
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (04) :298-304
[3]   Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma [J].
Opitz, I. ;
Sigrist, B. ;
Hillinger, S. ;
Lardinois, D. ;
Stahel, R. ;
Weder, W. ;
Hopkins-Donaldson, S. .
LUNG CANCER, 2007, 56 (03) :327-336
[4]   Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma [J].
Richards, WG ;
Zellos, L ;
Bueno, R ;
Jaklitsch, MT ;
Jänne, PA ;
Chirieac, LR ;
Yeap, BY ;
Dekkers, RJ ;
Hartigan, PM ;
Capalbo, L ;
Suarbaker, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (10) :1561-1567
[5]  
Rusch V, J THORAC CARDIOVASC
[6]   Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection [J].
Sugarbaker, David J. ;
Gill, Ritu R. ;
Yeap, Beow Y. ;
Wolf, Andrea S. ;
DaSilva, Marcelo C. ;
Baldini, Elizabeth H. ;
Bueno, Raphael ;
Richards, William G. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (04) :955-963
[7]   Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study [J].
Tilleman, Tamara R. ;
Richards, William G. ;
Zellos, Lambros ;
Johnson, Bruce E. ;
Jaklitsch, Michael T. ;
Mueller, Jordan ;
Yeap, Beow Yong ;
Mujoomdar, Aneil A. ;
Ducko, Christopher T. ;
Bueno, Raphael ;
Sugarbaker, David J. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (02) :405-411
[8]   Perspective on malignant pleural mesothelioma diagnosis and treatment [J].
Wald, Ori ;
Sugarbaker, David J. .
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (06)